McGA brings real-world expertise from leaders in health policy, reimbursement and market access, and cancer care to decision-makers in leading biotech and pharma companies, law and investment firms, and national associations. Our understanding of oncology and specialty clinical science and market nuances differentiates us among consulting firms.
At McGA, our expertise spans clinical sciences, guideline and compendium placement, health policy, biopharma marketing, market access, and health economics. We develop analyses, insights, submissions, financial models, and strategies specific to the clinical and competitive landscape of your product and portfolio. Our clients appreciate the depth of understanding and breadth of expertise we can bring to each project.
Our team includes experts who have built and led key organizations in market access and clinical care. Working cross-functionally allows us to provide clients with
comprehensive strategies to address challenging problems in oncology and specialty markets. We focus on developing long-lasting relationships and long-term strategies to keep our clients ahead of the competition.